Viewing Study NCT05681260

Bugs

Ignite Creation Date: 2025-12-25 @ 2:11 AM

Ignite Modification Date: 2025-12-30 @ 9:52 AM

Study NCT ID: NCT05681260

Status: RECRUITING

Last Update Posted: 2025-02-13

First Post: 2022-12-27

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

Sponsor: Children's Cancer Group, China

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Organization:

Class: NETWORK

Study ID: CCCG-T-LBL-2023

Study Type: None

Study Domain: None

Study Link: None

Lead Sponsor:

Lead Sponsor Class: NETWORK

Responsible Party:

Responsible Party Title:

Responsible Party Type: SPONSOR

Responsible Party Affiliation:

Old Name: None

Old Organization: None